Beck Mack & Oliver’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$165M Sell
616,631
-10,406
-2% -$2.82M 3.39% 11
2025
Q4
$157M Buy
627,037
+16,192
+3% +$4.3M 2.86% 12
2025
Q3
$175M Sell
610,845
-3,190
-0.5% -$855K 3.19% 11
2025
Q2
$161M Sell
614,035
-12,983
-2% -$3.16M 3.08% 11
2025
Q1
$146M Buy
627,018
+13,986
+2% +$3.39M 2.91% 10
2024
Q4
$141M Buy
613,032
+7,245
+1% +$1.66M 2.6% 12
2024
Q3
$135M Buy
605,787
+5,770
+1% +$1.27M 2.63% 11
2024
Q2
$122M Buy
600,017
+5,422
+0.9% +$1.1M 2.53% 11
2024
Q1
$130M Buy
594,595
+45,341
+8% +$9.99M 2.63% 11
2023
Q4
$125M Sell
549,254
-7,019
-1% -$1.47M 2.9% 10
2023
Q3
$112M Sell
556,273
-102,509
-16% -$21.6M 2.93% 9
2023
Q2
$137M Buy
658,782
+93,254
+16% +$18.1M 3.57% 9
2023
Q1
$111M Buy
565,528
+10,374
+2% +$2.13M 3.22% 9
2022
Q4
$112M Buy
555,154
+2,091
+0.4% +$409K 3.3% 9
2022
Q3
$97.3M Sell
553,063
-4,521
-0.8% -$926K 3.14% 10
2022
Q2
$112M Sell
557,584
-4,626
-0.8% -$986K 3.37% 8
2022
Q1
$127M Sell
562,210
-8,129
-1% -$1.91M 3.19% 8
2021
Q4
$154M Sell
570,339
-3,243
-0.6% -$803K 3.67% 7
2021
Q3
$139M Sell
573,582
-1,582
-0.3% -$399K 3.6% 7
2021
Q2
$136M Buy
575,164
+16,856
+3% +$3.84M 3.63% 7
2021
Q1
$122M Sell
558,308
-30,688
-5% -$6.16M 3.78% 5
2020
Q4
$103M Sell
588,996
-20,685
-3% -$3.57M 3.42% 8
2020
Q3
$98.6M Sell
609,681
-6,534
-1% -$1.04M 3.62% 7
2020
Q2
$87.9M Sell
616,215
-5,873
-0.9% -$813K 3.27% 8
2020
Q1
$67.5M Buy
622,088
+37,903
+6% +$5.46M 3% 10
2019
Q4
$84.9M Sell
584,185
-3,463
-0.6% -$500K 2.81% 11
2019
Q3
$84.8M Sell
587,648
-10,349
-2% -$1.51M 2.99% 10
2019
Q2
$88.8M Buy
597,997
+1,319
+0.2% +$184K 3.12% 9
2019
Q1
$78.4M Buy
596,678
+4,063
+0.7% +$501K 2.8% 12
2018
Q4
$64.3M Buy
592,615
+23,454
+4% +$3.14M 2.58% 12
2018
Q3
$84.9M Sell
569,161
-2,657
-0.5% -$404K 2.7% 11
2018
Q2
$88.2M Sell
571,818
-3,533
-0.6% -$533K 2.96% 9
2018
Q1
$80M Sell
575,351
-214
-0% -$31.4K 2.69% 13
2017
Q4
$78.9M Sell
575,565
-20,862
-3% -$2.76M 2.59% 12
2017
Q3
$77.4M Sell
596,427
-18,767
-3% -$2.5M 2.54% 12
2017
Q2
$81.5M Buy
615,194
+12,833
+2% +$1.57M 2.74% 11
2017
Q1
$74.2M Sell
602,361
-1,186
-0.2% -$140K 2.6% 10
2016
Q4
$66.6M Sell
603,547
-2,031
-0.3% -$226K 2.39% 14
2016
Q3
$71.5M Sell
605,578
-7,175
-1% -$845K 2.58% 10
2016
Q2
$68.6M Sell
612,753
-13,946
-2% -$1.5M 2.42% 9
2016
Q1
$63.1M Sell
626,699
-31,130
-5% -$2.98M 2.2% 16
2015
Q4
$69.9M Sell
657,829
-158,935
-19% -$16.4M 2.38% 13
2015
Q3
$76.1M Buy
816,764
+26,621
+3% +$2.75M 2.3% 13
2015
Q2
$82.3M Buy
790,143
+68,924
+10% +$7.17M 2.14% 15
2015
Q1
$78.1M Sell
721,219
-185,692
-20% -$19.1M 1.96% 17
2014
Q4
$84.1M Sell
906,911
-8,021
-0.9% -$708K 2.04% 15
2014
Q3
$80M Sell
914,932
-5,754
-0.6% -$520K 1.88% 22
2014
Q2
$81M Sell
920,686
-14,953
-2% -$1.3M 1.82% 22
2014
Q1
$78.9M Buy
935,639
+51,546
+6% +$4.11M 1.84% 21
2013
Q4
$69.4M Sell
884,093
-26,947
-3% -$2.3M 1.7% 22
2013
Q3
$77.6M Sell
911,040
-78,996
-8% -$6.65M 2.04% 20
2013
Q2
$85.1M Buy
+990,036
New +$82.2M 2.32% 14

Other funds holding LH

Beck Mack & Oliver's LH Position: Q1 2026 in Review

Beck Mack & Oliver reduced its Labcorp (LH) stake by 1.7% in Q1 2026, selling an estimated $2.82M and leaving 616,631 shares worth $165M. The position accounts for 3.39% of the portfolio, ranked #11.

Beck Mack & Oliver first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $175M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Beck Mack & Oliver held 616,631 shares of Labcorp worth $165M as of Q1 2026.
  • Beck Mack & Oliver sold 10,406 Labcorp shares in Q1 2026, an estimated $2.82M.
  • Labcorp made up 3.39% of Beck Mack & Oliver's portfolio in Q1 2026, its #11 holding.
  • Beck Mack & Oliver first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Beck Mack & Oliver's Labcorp position peaked at $175M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.